These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Feld JJ; Hoofnagle JH Nature; 2005 Aug; 436(7053):967-72. PubMed ID: 16107837 [TBL] [Abstract][Full Text] [Related]
27. Strategies for hepatitis C therapeutic intervention: now and next. Tan SL; He Y; Huang Y; Gale M Curr Opin Pharmacol; 2004 Oct; 4(5):465-70. PubMed ID: 15351350 [TBL] [Abstract][Full Text] [Related]
28. Obesity and its nurturing effect on hepatitis C. McCullough AJ Hepatology; 2003 Sep; 38(3):557-9. PubMed ID: 12939581 [No Abstract] [Full Text] [Related]
29. Therapy of acute hepatitis C. Alberti A; Boccato S; Vario A; Benvegnù L Hepatology; 2002 Nov; 36(5 Suppl 1):S195-200. PubMed ID: 12407594 [TBL] [Abstract][Full Text] [Related]
30. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same. Herion D; Hoofnagle JH Hepatology; 1997 Mar; 25(3):769-71. PubMed ID: 9049233 [No Abstract] [Full Text] [Related]
31. [Interferon therapy in chronic active viral hepatitis]. Lengyel G; Fehér J Orv Hetil; 1995 Jan; 136(1):3-7. PubMed ID: 7531317 [TBL] [Abstract][Full Text] [Related]
32. [Treatment of acute hepatitis C]. García Compeán D Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S61-6. PubMed ID: 12712857 [TBL] [Abstract][Full Text] [Related]
35. Interferon therapy in hepatitis C virus (HCV) induced chronic hepatitis: clinical significance of pretreatment with glycyrhizine. Fujisawa K Trop Gastroenterol; 1991; 12(4):176-9. PubMed ID: 1726032 [No Abstract] [Full Text] [Related]
36. [Hepatitis C and drug use: epidemiology, screening, natural history and treatment]. Lucidarme D Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B112-20. PubMed ID: 12180278 [No Abstract] [Full Text] [Related]
37. Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study. Bonny C; Fontaine H; Poynard T; Hézode C; Larrey D; Marcellin P; Bourlière M; Bronowicki JP; Merle P; Zarski JP; Sapey T; Guillemard C; Ughetto S; Henquell C; Nicolas C; Roche C; Randl K; Bommelaer G; Abergel A Aliment Pharmacol Ther; 2006 Aug; 24(4):593-600. PubMed ID: 16907892 [TBL] [Abstract][Full Text] [Related]
38. [Optimal antiviral therapy of chronic hepatitis caused by hepatitis C virus]. Cooreman MP; Stadhouders P Orv Hetil; 1997 Jun; 138(22 Suppl 1):1476-82. PubMed ID: 9221377 [TBL] [Abstract][Full Text] [Related]
39. New therapeutic strategies for hepatitis C. Di Bisceglie AM; McHutchison J; Rice CM Hepatology; 2002 Jan; 35(1):224-31. PubMed ID: 11786980 [No Abstract] [Full Text] [Related]
40. [The role of interferon in the treatment of viral hepatitis and its perspective]. Zhang DF Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):2-4. PubMed ID: 21272448 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]